Actionable news
0
All posts from Actionable news
Actionable news in MACK: Merrimack Pharmaceuticals, Inc.,

Exclusive: Cancer drugmaker Merrimack explores strategic alternatives - sources

Pancreatic cancer drug-maker Merrimack Pharmaceuticals (MACK.O) is working with investment banks on a strategic review that could result in a sale of some of its assets or a licensing deal, people familiar with the situation said on Wednesday.

Merrimack will seek to tap the growing interest in cancer treatments amid forecasts that they will be the greatest contributor to drug sale growth in the next five years. Already the largest driver of M&A this year, cancer drugs have caught the eyes of pharmaceutical giants AbbVie Inc (ABBV.N) and Pfizer Inc (PFE.N).

Cambridge, Massachusetts-based Merrimack has retained investment banks Credit Suisse AG (MLPN.P) and Bank of America Corp (BAC.N) for the review, the sources said, asking not to...


More